Skip to Main Content

Paper Details

Minimal residual disease monitoring in acute myeloid leukemia with non-A/B/D-NPM1 mutations by digital polymerase chain reaction: feasibility and clinical use.
Haematologica
7
2021
Author NameAffiliation
Emmanuel RaffouxSaint-Louis Hospital, Saint-Louis Research Institute, Universite de Paris
Raphael ItzyksonSaint-Louis Hospital, Saint-Louis Research Institute, Universite de Paris
Claude PreudhommeFRANCE University Lille, CNRS, Inserm, Institut de Recherche contre le Cancer de Lille
Herv?? DombretSaint-Louis Hospital, Saint-Louis Research Institute, Universite de Paris
  • 1 - 4

Datasets

Release 1.2